➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
Mallinckrodt
McKesson
Medtronic
AstraZeneca

Last Updated: August 3, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR BENZOYLECGONINE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Clinical Trials for Benzoylecgonine

Trial ID Title Status Sponsor Phase Summary
NCT00015067 Cocaine-Methylphendidate Interaction Study - 4 Completed Cincinnati MDRU Phase 1 The purpose of this study is to attempt to identify possible dangerous interactions between cocaine and methylphenidate (MPD). Additional objectives are to determine: a) if MPD reduces the craving and high for cocaine; b) if there are pharmacokinetic and pharmacodynamic interactions between cocaine and MPD; and c) the relationship between cocaine and benzoylecgonine (BE) levels in plasma and BE levels in urine.
NCT00015067 Cocaine-Methylphendidate Interaction Study - 4 Completed National Institute on Drug Abuse (NIDA) Phase 1 The purpose of this study is to attempt to identify possible dangerous interactions between cocaine and methylphenidate (MPD). Additional objectives are to determine: a) if MPD reduces the craving and high for cocaine; b) if there are pharmacokinetic and pharmacodynamic interactions between cocaine and MPD; and c) the relationship between cocaine and benzoylecgonine (BE) levels in plasma and BE levels in urine.
NCT00015080 Naltrexone in Treatment of Cocaine Dependence - 5 Completed Cincinnati MDRU Phase 2 The purpose of this study is to determine the efficacy of naltrexone in the treatment of cocaine dependence as measured by: 1) decreased urine benzoylecgonine (BE) levels, 2) decreased cocaine use by self-report, 3) decreased cocaine craving, and 4) retention in treatment.
NCT00015080 Naltrexone in Treatment of Cocaine Dependence - 5 Completed National Institute on Drug Abuse (NIDA) Phase 2 The purpose of this study is to determine the efficacy of naltrexone in the treatment of cocaine dependence as measured by: 1) decreased urine benzoylecgonine (BE) levels, 2) decreased cocaine use by self-report, 3) decreased cocaine craving, and 4) retention in treatment.
NCT00032929 Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1 Completed Somerset Pharmaceuticals Phase 3 The purpose of this study is to evaluate the Selegiline Transdermal System for the treatment of cocaine dependence.
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for Benzoylecgonine

Condition Name

Condition Name for
Intervention Trials
Cocaine Dependence 10
Cocaine-Related Disorders 5
Cocaine Addiction 1
Healthy 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for
Intervention Trials
Cocaine-Related Disorders 16
Hyperkinesis 1
Disease 1
Attention Deficit Disorder with Hyperactivity 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Benzoylecgonine

Trials by Country

Trials by Country for
Location Trials
United States 30
Brazil 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for
Location Trials
Ohio 5
Pennsylvania 5
Texas 4
Maryland 3
South Carolina 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Benzoylecgonine

Clinical Trial Phase

Clinical Trial Phase for
Clinical Trial Phase Trials
Phase 3 2
Phase 2/Phase 3 1
Phase 2 10
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for
Clinical Trial Phase Trials
Completed 14
Withdrawn 2
Recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Benzoylecgonine

Sponsor Name

Sponsor Name for
Sponsor Trials
National Institute on Drug Abuse (NIDA) 13
University of Pennsylvania 5
Cincinnati MDRU 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for
Sponsor Trials
Other 18
NIH 13
Industry 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
Harvard Business School
Johnson and Johnson
Colorcon
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.